Layer Yannik Christian, Mesropyan Narine, Isaak Alexander, Kravchenko Dmitrij, Bischoff Leon, Pieper Claus C, Kupczyk Patrick, Luetkens Julian A, Ernst Benjamin P, Kuetting Daniel
Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Quantitative Imaging Lab Bonn (QILaB), Bonn, Germany.
Eur Radiol Exp. 2025 Aug 15;9(1):77. doi: 10.1186/s41747-025-00618-6.
This experimental study aimed to compare the image quality of maxillofacial and temporal bone imaging using different radiation dose settings on current high-end CT systems: photon-counting detector CT (PCDCT), dual-source energy-integrating detector CT (DECT), and dual-layer spectral detector CT (SDCT).
CT scans of a cadaveric human specimen were investigated. Temporal bone imaging was performed with the following parameters: 120 kV and A (high-dose): 140-100 mAs; B (middle-dose): 90-60 mAs; C (low-dose): 50-25 mAs; D (ultra-low-dose): 20-10 mAs. Similarly, for maxillofacial CT: 100 kV and A: 100-80 mAs; B: 70-50 mAs; C: 40-25 mAs; D: 20-10 mAs. Region of interest (ROI)-based noise, SNR, and CNR ratios were calculated for objective assessment of image quality. Subjectively, image quality (IQ) of important anatomic landmarks was assessed using a Likert grading scale from 1 (non-diagnostic) to 5 (excellent).
For temporal bone, PCDCT provided excellent-to-good IQ up to low-dose scans for all anatomical landmarks, which was superior to SDCT (excellent-to-sufficient), followed by DECT (good-to-poor): e.g., for C: 4.3 ± 0.5 versus 3.7 ± 0.6 versus 2.9 ± 0.6, p < 0.001. PCDCT had significantly better IQ compared to SDCT in ultra-low-dose settings (D: 3.9 ± 0.4 versus 2.8 ± 0.4, p < 0.001). For maxillofacial CT, no significant differences in IQ were found between all CT systems using high- and middle-dose scans, e.g., B: 3.9 ± 0.5 versus 3.8 ± 0.7 versus 3.8 ± 0.4 (p = 0.81). In low- and ultra-low-dose settings, IQ was similar by PCDCT and SDCT (C: p = 0.17; D: p = 0.99) and superior to that of DECT (C: p < 0.05).
PCDCT offers excellent image quality for temporal bone and maxillofacial CT even at ultra-low doses; results were, in some cases, superior to SDCT and DECT.
As PCDCT outperformed modern DECT and SDCT in assessment of maxillofacial and temporal bone CT for image quality and radiation dose, our study suggests that the implementation of PCDCT will improve image quality while reducing radiation exposure in general population.
This work compares the quality of maxillofacial and temporal bone imaging in PCDCT, DECT, and SDCT. Scans of a cadaveric human specimen were investigated using different radiation doses. PCDCT offers excellent image quality for temporal bone and maxillofacial CT. PCDCT, SDCT, and DECT all showed good image quality overall.
本实验研究旨在比较当前高端CT系统(光子计数探测器CT(PCDCT)、双源能量积分探测器CT(DECT)和双层光谱探测器CT(SDCT))在不同辐射剂量设置下的颌面和颞骨成像的图像质量。
对一具尸体标本进行CT扫描研究。颞骨成像的参数如下:120 kV及A(高剂量):140 - 100 mAs;B(中剂量):90 - 60 mAs;C(低剂量):50 - 25 mAs;D(超低剂量):20 - 10 mAs。同样,颌面CT的参数为:100 kV及A:100 - 80 mAs;B:70 - 50 mAs;C:40 - 25 mAs;D:20 - 10 mAs。计算基于感兴趣区域(ROI)的噪声、信噪比(SNR)和对比噪声比(CNR),以客观评估图像质量。主观上,使用从1(非诊断性)到5(优秀)的李克特量表对重要解剖标志的图像质量(IQ)进行评估。
对于颞骨,PCDCT在所有解剖标志的低剂量扫描及以下都能提供优秀到良好的图像质量,优于SDCT(优秀到足够),其次是DECT(良好到较差):例如,对于C组:4.3 ± 0.5对比3.7 ± 0.6对比2.9 ± 0.6,p < 0.001。在超低剂量设置下(D组),PCDCT的图像质量明显优于SDCT(3.9 ± 0.4对比2.8 ± 0.4,p < 0.001)。对于颌面CT,在使用高剂量和中剂量扫描时,所有CT系统之间的图像质量没有显著差异,例如,B组:3.9 ± 0.5对比3.8 ± 0.7对比3.8 ± 0.4(p = 0.81)。在低剂量和超低剂量设置下,PCDCT和SDCT的图像质量相似(C组:p = 0.17;D组:p = 0.99)且优于DECT(C组:p < 0.05)。
即使在超低剂量下,PCDCT也能为颞骨和颌面CT提供优秀的图像质量;在某些情况下,结果优于SDCT和DECT。
由于PCDCT在颌面和颞骨CT的图像质量和辐射剂量评估方面优于现代的DECT和SDCT,我们的研究表明,PCDCT的应用将提高图像质量,同时减少普通人群的辐射暴露。
本研究比较了PCDCT、DECT和SDCT中颌面和颞骨成像的质量。使用不同辐射剂量对一具尸体标本进行扫描。PCDCT为颞骨和颌面CT提供优秀的图像质量。PCDCT、SDCT和DECT总体上均显示出良好的图像质量。